Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Peramivir vs Oseltamivir in High-Risk Adults With Influenza
CTR20131184Phase 3Active
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of peramivir in Influenza A infection, influenza B, sponsored by Hengrui Therapeutics. Started Jan 2014; status: active.
02
Drugs
peramivir
03
Conditions
Influenza A infectioninfluenza B
Beyond the preview
Go deeper on CTR20131184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131184.